Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Morschhauser

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
Hematology/Oncology Clinics of North America|June 27, 2020
Immunomodulatory Agents in Follicular LymphomaLoic Ysebaert, Franck Morschhauser
Best Practice & Research. Clinical Haematology|June 11, 2011
Radioimmunotherapy in follicular lymphomaTim Illidge, Franck Morschhauser
Blood|November 14, 2024
Building the future management of follicular lymphoma with T-cell-redirecting strategiesGloria Iacoboni, Franck Morschhauser
Expert Opinion on Investigational Drugs|June 7, 2011
Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trials in light of recent advances in the biology of B-cell malignanciesLoic Ysebaert, Franck Morschhauser
Hematology. American Society of Hematology. Education Program|December 5, 2025
Selecting the best treatment approach and optimizing sequencing strategies in large B-cell lymphomaGloria Iacoboni, Franck Morschhauser
Current Oncology Reports|August 17, 2011
Ongoing development of monoclonal antibodies and antibody drug-conjugates in lymphomaEileen M Boyle, Franck Morschhauser
Expert Opinion on Drug Safety|February 27, 2015
Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphomaEileen Mary Boyle, Franck Morschhauser
Current Opinion in Oncology|July 7, 2021
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatmentGamze Tari, François Lemonnier, Franck Morschhauser
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2020
Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin LymphomaBruce D Cheson, Franck Morschhauser, Peter Martin
The Lancet. Haematology|August 28, 2020
Total immunotherapy for Hodgkin lymphomaRoch Houot, Reid W Merryman, Franck Morschhauser
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
Hematology/Oncology Clinics of North America|June 27, 2020
Immunomodulatory Agents in Follicular LymphomaLoic Ysebaert, Franck Morschhauser
Best Practice & Research. Clinical Haematology|June 11, 2011
Radioimmunotherapy in follicular lymphomaTim Illidge, Franck Morschhauser
Blood|November 14, 2024
Building the future management of follicular lymphoma with T-cell-redirecting strategiesGloria Iacoboni, Franck Morschhauser
Expert Opinion on Investigational Drugs|June 7, 2011
Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trials in light of recent advances in the biology of B-cell malignanciesLoic Ysebaert, Franck Morschhauser
Hematology. American Society of Hematology. Education Program|December 5, 2025
Selecting the best treatment approach and optimizing sequencing strategies in large B-cell lymphomaGloria Iacoboni, Franck Morschhauser
Current Oncology Reports|August 17, 2011
Ongoing development of monoclonal antibodies and antibody drug-conjugates in lymphomaEileen M Boyle, Franck Morschhauser
Expert Opinion on Drug Safety|February 27, 2015
Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphomaEileen Mary Boyle, Franck Morschhauser
Current Opinion in Oncology|July 7, 2021
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatmentGamze Tari, François Lemonnier, Franck Morschhauser
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2020
Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin LymphomaBruce D Cheson, Franck Morschhauser, Peter Martin
The Lancet. Haematology|August 28, 2020
Total immunotherapy for Hodgkin lymphomaRoch Houot, Reid W Merryman, Franck Morschhauser
Pageof 32